Galenic formulations of argatroban for subcutaneous administration

摘要

This invention is concerned with new formulations of argatroban for subcutaneous administration. These new formulations can be of quick release or slow release type. The formulations have the form of argatroban crystals. The argatroban concentration may lie between 1 and 100 mg/ml.